|
04.07.25 - 10:15
|
Full-day Takeaway: HSI Closes at 23,916, Down 153 pts; HSTI Closes at 5,216, Down 17 pts; ALI HEALTH Down over 6%; CCB, J&T EXPRESS-W, AKESO, MINSHENG BANK, XD INC Hit New Highs; Market Turnover Rises (AAStocks)
|
|
At close, HSI dropped 153 pts or 0.6% to 23,916. HSTI dropped 17 pts or 0.3% to 5,216. HSCEI fell 39 pts or 0.5% to 8,609. Market turnover reached $267.81 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $120.8, down 1.6%BABA (09988.HK) closed at $105.1, down 1%XIAOMI (01810.HK) closed at $57.5, down 1%TENCENT (00700.HK)......
|
|
04.07.25 - 06:15
|
Midday Takeaway: HSI Closes Midday at 23,921, Down 148 pts; HSTI Closes Midday at 5,209, Down 24 pts; ALI HEALTH Down over 6%; AKESO, KB LAMINATES Hit New Highs (AAStocks)
|
|
At midday close, HSI dropped 148 pts or 0.6% to 23,921. HSTI dropped 24 pts or 0.5% to 5,209. HSCEI fell 36 pts or 0.4% to 8,611.Active Heavyweights:XIAOMI (01810.HK) closed at $57.4, down 1.2%MEITUAN (03690.HK) closed at $121.7, down 0.9%PING AN (02318.HK) closed at $49.7, down 0.8%HKEX (00388.HK) closed at $414.8, down 0.6%BAB......
|
|
|
|
03.07.25 - 12:30
|
HKD3.2B Southbound Trading Net Outflow from BABA-W (AAStocks)
|
|
There was HKD987.4 million and HKD22.7 million Southbound Trading net inflow to MEITUAN-W (03690.HK) and XIAOMI-W (01810.HK).There was HKD3.2 billion, HKD885.3 million and HKD739.9 million Southbound Trading net outflow from BABA-W (09988.HK), TENCENT (00700.HK) and AKESO (09926.HK).For Southbound Trading of Shanghai-Hong Kong S......
|
|
03.07.25 - 10:33
|
HUTCHMED to Announce 2025 Half-Year Financial Results (GlobeNewswire EN)
|
|
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 03, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2025 on Thursday, August 7, 2025 at 7:00 am Eastern Daylight Time (EDT) / 12:00 noon British Summer Time (BST) / 7:00 pm Hong Kong Time (HKT)....
|
|
03.07.25 - 10:15
|
Full-day Takeaway: HSI Closes at 24,069, Down 151 pts; HSTI Closes at 5,233, Down 35 pts; XIAOMI Down over 3%; ZIJIN MINING, AKESO, KB LAMINATES, ASCENTAGE, GLOBAL NEW MAT Hit New Highs; Market Turnover Rises (AAStocks)
|
|
At close, HSI dropped 151 pts or 0.6% to 24,069. HSTI dropped 35 pts or 0.7% to 5,233. HSCEI fell 76 pts or 0.9% to 8,648. Market turnover reached $231.25 billion.Active Heavyweights:XIAOMI (01810.HK) closed at $58.1, down 3.4%BABA (09988.HK) closed at $106.2, down 2.9%MEITUAN (03690.HK) closed at $122.8, down 2.5%HKEX (00388.HK......
|
|
|
03.07.25 - 06:30
|
Midday Takeaway: HSI Closes Midday at 23,989, Down 232 pts; HSTI Closes Midday at 5,205, Down 63 pts; XIAOMI Down over 4%; BABA Down over 3%; HENDERSON LAND, XINYI ENERGY, ASCENTAGE, GLOBAL NEW MAT, GREAT EAGLE H Hit New Highs (AAStocks)
|
|
At midday close, HSI dropped 232 pts or 1.0% to 23,989. HSTI dropped 63 pts or 1.2% to 5,205. HSCEI fell 108 pts or 1.2% to 8,616.Active Heavyweights:XIAOMI (01810.HK) closed at $57.5, down 4.4%BABA (09988.HK) closed at $105.5, down 3.6%MEITUAN (03690.HK) closed at $122.9, down 2.5%HKEX (00388.HK) closed at $417.6, down 1.3%TENC......
|
|
|
|
|
|
|
02.07.25 - 06:45
|
Research: Citi Raises INNOVENT BIO's TP to HKD90; New Phase Begins (AAStocks)
|
|
INNOVENT BIO (01801.HK)'s IBI363 (PD-1/IL-2alpha-bias bispecific antibody fusion protein product) has been highlighted by opinion leaders for its promising data and potential to become a key product in next-generation immuno-oncology (IO) treatment, Citi published a research report noting.In Citi's opinion, INNOVENT BIO ......
|
|
|
02.07.25 - 05:30
|
On Move: SIPAI HEALTH Once Hyped Up 49% w/ Turnover Surpassing HKD1B (AAStocks)
|
|
SIPAI HEALTH (00314.HK) opened sharply higher by 14.2% this morning (2nd) and once climbed to an over three-month high of HKD6.93 with a surge of 49.4% in early trading. It last traded at HKD5.91, up 27.37%, with a volume surging to 167 million shares, involving HKD1.058 billion, making it one of the top 20 most active stocks by......
|
|
|
|
01.07.25 - 12:36
|
Zura Bio Announces Chief Financial Officer Transition (Business Wire)
|
|
HENDERSON, Nev.--(BUSINESS WIRE)--$ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for a range of autoimmune and inflammatory diseases, today announced the appointment of Eric Hyllengren as Chief Financial Officer, effective July 7, 2025. He will succeed Verender Badial, who will step down from the role and remain with the company as a non-executive employee through July 31, 2025, to support a seamless transition.
Mr. Badial joined Zura Bio in March 2023, at the time of its business combination with JATT Acquisition Corporation. He led the development of Zura Bio's internal financial and operational systems, contributed to shaping its financial strategy, and participated in capital-raising efforts that supported the company's early growth.
Mr. Hyllengren brings over 20 years of financial leadership experience in the life sciences and biotechnology sectors. He most recently served as Chief Operatin...
|
|